These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 8494051)
1. Pancreatic adenocarcinomas frequently show p53 gene mutations. Scarpa A; Capelli P; Mukai K; Zamboni G; Oda T; Iacono C; Hirohashi S Am J Pathol; 1993 May; 142(5):1534-43. PubMed ID: 8494051 [TBL] [Abstract][Full Text] [Related]
2. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas. Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192 [TBL] [Abstract][Full Text] [Related]
3. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations. Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992 [TBL] [Abstract][Full Text] [Related]
4. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer. Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039 [TBL] [Abstract][Full Text] [Related]
5. Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival. Sessa F; Bonato M; Bisoni D; Ranzani GN; Capella C Eur J Histochem; 1998; 42 Spec No():67-76. PubMed ID: 10076772 [TBL] [Abstract][Full Text] [Related]
6. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [TBL] [Abstract][Full Text] [Related]
7. p53 alterations in chemically induced hamster cheek-pouch lesions. Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462 [TBL] [Abstract][Full Text] [Related]
8. [P53 gene mutation in gallbladder cancer]. Roa I; Melo A; Roa J; Araya J; Villaseca M; de Aretxabala X Rev Med Chil; 2000 Mar; 128(3):251-8. PubMed ID: 10962865 [TBL] [Abstract][Full Text] [Related]
9. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status. Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163 [TBL] [Abstract][Full Text] [Related]
10. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Hoorens A; Lemoine NR; McLellan E; Morohoshi T; Kamisawa T; Heitz PU; Stamm B; Rüschoff J; Wiedenmann B; Klöppel G Am J Pathol; 1993 Sep; 143(3):685-98. PubMed ID: 8362971 [TBL] [Abstract][Full Text] [Related]
12. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein. Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467 [TBL] [Abstract][Full Text] [Related]
13. Mutations of p53 gene in gastric carcinoma in Taiwan. Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797 [TBL] [Abstract][Full Text] [Related]
17. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study. Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886 [TBL] [Abstract][Full Text] [Related]
18. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067 [TBL] [Abstract][Full Text] [Related]
19. Association of p53 mutations with metastatic prostate cancer. Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901 [TBL] [Abstract][Full Text] [Related]
20. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. Fujii K; Yokozaki H; Yasui W; Kuniyasu H; Hirata M; Kajiyama G; Tahara E Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):461-6. PubMed ID: 8781743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]